JavaScript is disabled for your browser. Some features of this site may not work without it.
Estadísticas
Número total de visitas
| Vistas | |
|---|---|
| Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial | 140 |
Visitas al mes
| enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | mayo 2024 | junio 2024 | julio 2024 | |
|---|---|---|---|---|---|---|---|
| Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial | 3 | 3 | 1 | 7 | 2 | 8 | 2 |
Países con más visualizaciones
| Vistas |
|---|
Ciudades con más visualizaciones
| Vistas |
|---|
